The acquisition itself is already known, so this filing is mainly validation rather than a new catalyst. Martin Marietta announced the Lhoist transaction on June 29, 2026, at an enterprise value of approximately $13.5 billion, funded with $7.0 billion of cash and $6.5 billion of Martin Marietta stock; closing was expected in the second half of 2026. The August 10 filing supplies SEC-compliant audited financials for the target, but does not change the announced price, structure, or timing.
Lhoist delivered a strong 2025 operating profile, supporting the deal’s strategic rationale. Revenue rose 5.0% to $1.754 billion, operating income increased 15.0% to $683.0 million, and net income grew 17.1% to $513.8 million. Operating cash flow also improved 10.7% to $556.3 million. (Statements of Income; Cash Flow statement)
| $ millions | 2025 | 2024 | Change |
|---|---|---|---|
| Revenue | 1,753.7 | 1,670.3 | +5.0% |
| Gross profit | 820.0 | 757.6 | +8.2% |
| Income from operations | 683.0 | 594.1 | +15.0% |
| Net income | 513.8 | 438.6 | +17.1% |
| Cash flow from operations | 556.3 | 502.4 | +10.7% |
| Capital expenditures | 150.7 | 95.4 | +57.9% |
| Long-term debt, including current portion | 955.6 | 1,019.1 | -6.2% |
The numbers are favorable versus the basic pre-deal picture, but there is no published standalone consensus to establish a precise beat or miss. Lhoist was private, so the filing does not provide an analyst EPS or revenue benchmark. Instead, it shows a business with rising sales, expanding operating profit, and lower debt before the transaction—although 2025 cash generation was partly absorbed by $500.0 million of dividends and $150.7 million of capital spending. (Statements of Equity; Cash Flow statement)
The restatement is mostly an SEC reporting uplift, not a fresh operating problem. The auditor emphasized that Lhoist’s prior financial statements were restated to comply with Regulation S-X and public-company reporting requirements for the acquisition. The 2025 uplift reduced reported net income from $516.2 million under private-company GAAP to $513.8 million under the SEC basis, while the 2024 restatement increased net income from $420.9 million to $438.6 million. (Independent Auditor’s Report; Note 1—Public Company Adoption Adjustments) The filing says the audit opinion was not modified.
Net read: financially supportive, informationally routine. The target’s profitability and cash flow make the announced roughly 15x adjusted-EBITDA transaction valuation—including expected synergies—look supported by a high-quality earnings base, but the market already knew the transaction economics and management’s synergy case. Without a published target-company consensus, this filing is best read as confirmation of the deal thesis rather than a measurable earnings surprise.
Read the original 8-K on SEC EDGAR ↗